• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Longitudinal Cytokine Profiling in Patients with Severe COVID-19 on Extracorporeal Membrane Oxygenation and Hemoadsorption.

作者信息

Lebreton Guillaume, Dorgham Karim, Quentric Paul, Combes Alain, Gorochov Guy, Schmidt Matthieu

机构信息

Sorbonne Université Paris, France.

Service de chirurgie cardiaque, Institut de Cardiologie Hopital Pitie Salpetrière Paris, France.

出版信息

Am J Respir Crit Care Med. 2021 Jun 1;203(11):1433-1435. doi: 10.1164/rccm.202011-4140LE.

DOI:10.1164/rccm.202011-4140LE
PMID:33725469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8456531/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbbc/8456531/5ee0c7ec5904/rccm.202011-4140LEf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbbc/8456531/5ee0c7ec5904/rccm.202011-4140LEf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbbc/8456531/5ee0c7ec5904/rccm.202011-4140LEf1.jpg

相似文献

1
Longitudinal Cytokine Profiling in Patients with Severe COVID-19 on Extracorporeal Membrane Oxygenation and Hemoadsorption.接受体外膜肺氧合和血液吸附治疗的重症新型冠状病毒肺炎患者的纵向细胞因子分析
Am J Respir Crit Care Med. 2021 Jun 1;203(11):1433-1435. doi: 10.1164/rccm.202011-4140LE.
2
Organization of extracorporeal membrane oxygenation services for COVID-19.COVID-19 体外膜肺氧合服务的组织。
Asian Cardiovasc Thorac Ann. 2021 Mar;29(3):165-169. doi: 10.1177/0218492320962932. Epub 2020 Sep 30.
3
High In-Hospital Mortality Rate in Patients with COVID-19 Receiving Extracorporeal Membrane Oxygenation in Germany: A Critical Analysis.德国接受体外膜肺氧合治疗的新冠病毒疾病患者的院内死亡率较高：一项批判性分析。
Am J Respir Crit Care Med. 2021 Oct 15;204(8):991-994. doi: 10.1164/rccm.202105-1145LE.
4
Pregnant and Peripartum Women with COVID-19 Have High Survival with Extracorporeal Membrane Oxygenation: An Extracorporeal Life Support Organization Registry Analysis.患有新冠肺炎的孕妇和围产期妇女接受体外膜肺氧合治疗后生存率较高：体外生命支持组织注册分析
Am J Respir Crit Care Med. 2022 Jan 15;205(2):248-250. doi: 10.1164/rccm.202109-2096LE.
5
Survival of Pregnant Coronavirus Patient on Extracorporeal Membrane Oxygenation.孕妇感染冠状病毒患者接受体外膜肺氧合治疗后存活。
Ann Thorac Surg. 2021 Mar;111(3):e151-e152. doi: 10.1016/j.athoracsur.2020.09.004. Epub 2020 Oct 9.
6
Extracorporeal membrane oxygenation for COVID-19 during first and second waves.新冠疫情第一波和第二波期间用于治疗新冠病毒病的体外膜肺氧合
Lancet Respir Med. 2021 Aug;9(8):e80-e81. doi: 10.1016/S2213-2600(21)00262-9. Epub 2021 Jun 16.
7
ECMO during the COVID-19 pandemic: When is it justified?新型冠状病毒肺炎大流行期间的体外膜肺氧合：何时才合理？
Crit Care. 2020 Nov 19;24(1):650. doi: 10.1186/s13054-020-03386-4.
8
Cytokine Adsorption Therapy during Extracorporeal Membrane Oxygenation in Adult Patients with COVID-19.细胞因子吸附疗法在 COVID-19 成人患者体外膜肺氧合中的应用。
Blood Purif. 2022;51(9):791-798. doi: 10.1159/000518712. Epub 2021 Dec 2.
9
Successfully treatment of application awake extracorporeal membrane oxygenation in critical COVID-19 patient: a case report.成功应用清醒体外膜肺氧合治疗重症新型冠状病毒肺炎患者：一例报告
J Cardiothorac Surg. 2020 Dec 17;15(1):335. doi: 10.1186/s13019-020-01376-9.
10
A Patient with COVID-19 Treated with ECMO for 26 Days.一名接受体外膜肺氧合（ECMO）治疗26天的新冠肺炎患者。
J Coll Physicians Surg Pak. 2020 Oct;30(10):171-173. doi: 10.29271/jcpsp.2020.supp2.S171.

引用本文的文献

1
Critical risks of haemoadsorption for COVID-19 patients and directions for future evaluations: a nationwide propensity score matched cohort study.COVID-19患者血液吸附的关键风险及未来评估方向：一项全国性倾向评分匹配队列研究
Sci Rep. 2025 Aug 9;15(1):29184. doi: 10.1038/s41598-025-13860-0.
2
The COSMOS Registry of CytoSorb Hemoadsorption Therapy in Critically Ill Patients: Protocol for an International, Prospective Registry.《COSMOS 细胞吸附治疗危重症患者的注册研究：一项国际性前瞻性注册研究方案》
JMIR Res Protoc. 2024 Nov 5;13:e55880. doi: 10.2196/55880.
3
Hemoadsorption in acute respiratory distress syndrome patients requiring venovenous extracorporeal membrane oxygenation: a systematic review.

本文引用的文献

1
Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes.严重和危重新冠肺炎中的细胞因子升高：快速系统评价、荟萃分析，并与其他炎症综合征比较。
Lancet Respir Med. 2020 Dec;8(12):1233-1244. doi: 10.1016/S2213-2600(20)30404-5. Epub 2020 Oct 16.
2
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study.体外膜肺氧合治疗 COVID-19 相关严重急性呼吸窘迫综合征的回顾性队列研究。
Lancet Respir Med. 2020 Nov;8(11):1121-1131. doi: 10.1016/S2213-2600(20)30328-3. Epub 2020 Aug 13.
3
行静脉-静脉体外膜肺氧合的急性呼吸窘迫综合征患者的血液吸附治疗：系统评价。
Respir Res. 2024 Jan 12;25(1):27. doi: 10.1186/s12931-024-02675-8.
4
Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry.在接受 VV ECMO 的危重症 COVID-19 患者中进行体外血液吸附：COVID-19 中的 CytoSorb 治疗（CTC）登记研究。
Crit Care. 2023 Jun 19;27(1):243. doi: 10.1186/s13054-023-04517-3.
5
Efficacy of CytoSorb®: a systematic review and meta-analysis.CytoSorb® 的疗效：系统评价和荟萃分析。
Crit Care. 2023 May 31;27(1):215. doi: 10.1186/s13054-023-04492-9.
6
CytoSorb in patients with coronavirus disease 2019: A rapid evidence review and meta-analysis.细胞因子吸附剂在 2019 冠状病毒病患者中的应用：快速证据回顾和荟萃分析。
Front Immunol. 2023 Jan 31;14:1067214. doi: 10.3389/fimmu.2023.1067214. eCollection 2023.
7
Very Low Driving-Pressure Ventilation in Patients With COVID-19 Acute Respiratory Distress Syndrome on Extracorporeal Membrane Oxygenation: A Physiologic Study.体外膜肺氧合治疗的 COVID-19 急性呼吸窘迫综合征患者的低驱动压通气：一项生理学研究。
J Cardiothorac Vasc Anesth. 2023 Mar;37(3):423-431. doi: 10.1053/j.jvca.2022.11.033. Epub 2022 Nov 28.
8
Apheresis and COVID-19 in intensive care unit (ICU).血浆治疗与重症监护病房（ICU）中的 COVID-19。
Transfus Apher Sci. 2022 Dec;61(6):103593. doi: 10.1016/j.transci.2022.103593. Epub 2022 Nov 1.
9
Hemoperfusion in the intensive care unit.血液灌流在重症监护病房中的应用。
Intensive Care Med. 2022 Oct;48(10):1397-1408. doi: 10.1007/s00134-022-06810-1. Epub 2022 Aug 19.
10
Use of proton pump inhibitors are associated with higher mortality in hospitalized patients with COVID-19.质子泵抑制剂的使用与 COVID-19 住院患者的死亡率升高有关。
J Glob Health. 2022 Feb 19;12:05005. doi: 10.7189/jogh.12.05005. eCollection 2022.
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation.
需要体外膜肺氧合的重症新型冠状病毒肺炎患者的细胞因子吸附
Crit Care. 2020 Jul 14;24(1):435. doi: 10.1186/s13054-020-03130-y.
4
Use of hemoadsorption in sepsis-associated ECMO-dependent severe ARDS: A case series.血液吸附在脓毒症相关体外膜肺氧合支持的严重急性呼吸窘迫综合征中的应用：病例系列
J Intensive Care Soc. 2020 May;21(2):183-190. doi: 10.1177/1751143718818992. Epub 2019 Jan 8.
5
COVID-19, ECMO, and lymphopenia: a word of caution.新型冠状病毒肺炎、体外膜肺氧合与淋巴细胞减少：一则警示
Lancet Respir Med. 2020 Apr;8(4):e24. doi: 10.1016/S2213-2600(20)30119-3. Epub 2020 Mar 13.
6
Ultra-Protective Ventilation Reduces Biotrauma in Patients on Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome.体外膜肺氧合治疗严重急性呼吸窘迫综合征患者的超保护性通气减少生物创伤。
Crit Care Med. 2019 Nov;47(11):1505-1512. doi: 10.1097/CCM.0000000000003894.
7
Mechanical Ventilation Management during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. An International Multicenter Prospective Cohort.体外膜肺氧合治疗急性呼吸窘迫综合征时的机械通气管理。一项国际多中心前瞻性队列研究。
Am J Respir Crit Care Med. 2019 Oct 15;200(8):1002-1012. doi: 10.1164/rccm.201806-1094OC.
8
Continuous renal replacement therapy reduces the systemic and pulmonary inflammation induced by venovenous extracorporeal membrane oxygenation in a porcine model.连续性肾脏替代疗法可降低猪模型中静脉-静脉体外膜肺氧合引起的全身和肺部炎症。
Artif Organs. 2014 Mar;38(3):215-23. doi: 10.1111/aor.12154. Epub 2013 Dec 11.
9
The effect of venovenous extra-corporeal membrane oxygenation (ECMO) therapy on immune inflammatory response of cerebral tissues in porcine model.静脉-静脉体外膜肺氧合（ECMO）治疗对猪模型脑组织免疫炎症反应的影响。
J Cardiothorac Surg. 2013 Aug 29;8:186. doi: 10.1186/1749-8090-8-186.
10
Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine.由于肠道中预先形成的储存物的释放，ECMO 相关 SIRS 期间炎症细胞因子的血浆浓度会迅速升高。
Lab Invest. 2010 Jan;90(1):128-39. doi: 10.1038/labinvest.2009.119. Epub 2009 Nov 9.